Normal Absolute Monocyte Count at the Time of Relapse is Associated with Improved Survival After First Salvage Therapy in Adult Patients with Early Relapsed B-Lineage Acute Lymphoblastic Leukemia.

Yi-Fen ShiNa WangZi-Yang HuangRong-Rong ChenYi-Sha HuangYi-Yi ZhuChong-Yun XingBin LiangKang YuJian-Hua Feng

Published in: Cancer management and research (2020)

AMC at the time of relapse, which can be easily derived from routine clinical laboratory testing of complete blood count, might be used as a prognostic marker for survival outcomes in adult patients with early relapsed B-ALL.

Keyphrases

acute lymphoblastic leukemia
allogeneic hematopoietic stem cell transplantation
acute myeloid leukemia
peripheral blood
hodgkin lymphoma
multiple myeloma
diffuse large b cell lymphoma
free survival
dendritic cells
stem cells
endothelial cells
cell therapy
smoking cessation
cell fate